Lilly shares fell 10% on Thursday due to CVS Health's decision to drop the obesity drug Zepbound from some lists of medicines it covers for reimbursement, while Medicare kickback allegations have prompted the federal government to take action against health insurance companies Aetna,

The Justice Department accused large insurers of colluding with national brokers to steer older people and those with disabilities toward coverage that might not offer the best medical care.